search
Back to results

Bioactive Compounds in Watermelon Modulating Oxidative Stress and Inflammation in Elders (MOXIE)

Primary Purpose

Arterial Stiffness, Inflammation

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
100% watermelon juice
Placebo beverage
Sponsored by
University of Alabama, Tuscaloosa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Arterial Stiffness

Eligibility Criteria

55 Years - 69 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Ambulatory
  • Female
  • Age 55-69 years
  • Body mass index 18.5 - 29.9 kg/m2 (non-obese)

Exclusion Criteria:

  • Food allergy to watermelon
  • History of hypotension, chronic hypertension, chronic kidney disease, diabetes, previous cardiac events or procedures, phenylketonuria
  • Smoking or other tobacco use
  • Use of anticoagulant medications, cholesterol-lowering medications, blood-pressure medications, vasodilatory dietary supplements (garlic, fish oil), or dietary supplements containing lycopene, ascorbic acid, L-glutamine, L-arginine, or L-citrulline
  • Weight change > 10% in the previous year

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    Consumption of 100% watermelon juice

    Consumption of a placebo beverage

    Arm Description

    Consumption of two 12-ounce doses of pasteurized 100% watermelon juice for a four-week period

    Consumption of a placebo beverage with comparable sugar content, pH, taste, texture, and color for a four-week period

    Outcomes

    Primary Outcome Measures

    Change From Baseline in Serum Levels of Lycopene at 4 Weeks
    Lycopene determined by ultra high performance liquid chromatography with photodiode array detector (UPLC-PDA).
    Change in Vascular Endothelial Function at 4 Weeks
    Determined by brachial artery flow-mediated dilation (FMD). FMD uses ultrasound technology to quantify changes in brachial artery diameter in response to hyperemia. A blood pressure cuff was placed distal to the brachial artery of the right arm with the participant supine and rested. Pre-inflation diameter was recorded for one minute, and the cuff was inflated to 50 mmHg above resting SBP for five minutes. Then, images were recorded for 120 seconds after cuff deflation. Peak diameter was determined as an average of the five highest measurements over five seconds post-deflation. FMD was expressed as the percentage increase in peak diameter.
    Change in Arterial Stiffness at 4 Weeks
    Determined by pulse wave velocity (PWV). A cuff-based system was used to measure brachial oscillometric pressure waveforms and generate central pressure curves by propriety algorithms. PWV was quantified as the rate at which a pulse wave moves down a vessel.

    Secondary Outcome Measures

    Full Information

    First Posted
    July 24, 2018
    Last Updated
    May 16, 2022
    Sponsor
    University of Alabama, Tuscaloosa
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03626168
    Brief Title
    Bioactive Compounds in Watermelon Modulating Oxidative Stress and Inflammation in Elders
    Acronym
    MOXIE
    Official Title
    Bioactive Compounds in Watermelon Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2022
    Overall Recruitment Status
    Completed
    Study Start Date
    February 16, 2016 (Actual)
    Primary Completion Date
    May 12, 2018 (Actual)
    Study Completion Date
    May 12, 2018 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Alabama, Tuscaloosa

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Watermelon is the only food with a unique combination of amino acids and antioxidants that may reduce artery stiffness. However, only 27% of older adults meet the daily recommendation for fruit intake. Because it tastes good and is convenient and easy to consume, watermelon juice is an innovative and impactful intervention to help elders easily meet recommendations for fruit servings. If effective, this intervention would be a simple, inexpensive way to combat cardiovascular diseases (CVD). Results will advance science by providing a better understanding whether four-week consumption of 100% watermelon juice may impact measures of vascular health and inflammation in postmenopausal women.
    Detailed Description
    Purpose and Objectives: Vascular endothelial dysfunction is an early independent predictor of cardiovascular diseases (CVD), the leading cause of death for women ages 60 and older in the United States1. It is well-known that age-related decreases in vascular endothelial function are partially due to increases in oxidative stress and inflammation.In attempts to combat CVD, previous intervention studies have investigated provision of isolated bioactive food compounds (BFC) in supplemental form. For example, purified lycopene has been shown to decrease oxidative stress, and our previous work supports the supplemental use of glutamine and arginine in improving vascular endothelial function of older adults. Arginine is a precursor for the vasodilatory molecule nitric oxide (NO), and both glutamine and arginine have been shown to attenuate inflammation. Thus, if supplemented together, these compounds would be expected to exert synergist mechanistic effects that improve vascular function. Watermelon is one of the richest sources of lycopene, and it is among the greatest plant sources of arginine and glutamine. Watermelon also provides high amounts of citrulline (a precursor of arginine) along with the antioxidant ascorbic acid, which enhances the antioxidant and anti-inflammatory effects of carotenoids such as lycopene in biological samples. To date, clinical studies evaluating the potential synergy of these compounds provided by the whole food are lacking on mechanistic and clinical outcomes of CVD. The effects of watermelon supplementation on robust measures of vascular function, inflammation, and oxidative stress in women ages 60 and older are unknown. This study will evaluate the possible impact of multiple bioactive compounds in the natural food matrix of watermelon in order to fully characterize their potential synergy and their influence on CVD risk. Specifically, our proposed study seeks to evaluate the influence of bioactive compounds in 100% watermelon juice, a convenient serving alternative to fresh fruit, using a randomized, double-blind placebo-controlled trial with a crossover design. Specific Aims: Mechanistic: To determine whether community-dwelling, non-obese women ages 55-69 consuming two 12-ounce servings of 100% watermelon juice per day versus placebo for four weeks will demonstrate: increases in circulating levels of serum lycopene, citrulline, and arginine using ultra high performance liquid chromatography with photodiode array detector (UPLC-PDA). improvement in antioxidant status as assessed by the oxygen radical absorbance capacity assay (ORAC) of whole and deproteinated serum decreases in circulating biomarkers of inflammation Hypotheses: Four-week dietary supplementation with 100% watermelon juice will result in increased antioxidant capacity and decreased inflammation, related to increased serum lycopene, citrulline, and arginine Clinical: To determine whether community-dwelling, women ages 55-69 consuming two 12-ounce servings of 100% watermelon juice per day versus placebo for four weeks will exhibit: improved vascular endothelial function as assessed by flow-mediated dilation (FMD) and decreased arterial stiffness as assessed by pulse wave analysis (PWA) decreased low density lipoprotein (LDL) oxidation as assessed by enzyme immunoassay Hypotheses: Four-week dietary supplementation with 100% watermelon juice will result in improved vascular endothelial function, decreased arterial stiffness, and decreased LDL oxidation.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Arterial Stiffness, Inflammation

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Model Description
    In a double-blind crossover design, women ages 55-69 years were randomized to two 12-ounce servings of 100% watermelon juice per day or an isocaloric placebo for four weeks each with a 2-week washout period in between.
    Masking
    ParticipantInvestigatorOutcomes Assessor
    Masking Description
    In this crossover design, the participants principal investigators, and outcomes assessors were blinded as to which treatment (100% watermelon juice or placebo) was consumed at each time.
    Allocation
    Non-Randomized
    Enrollment
    21 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Consumption of 100% watermelon juice
    Arm Type
    Active Comparator
    Arm Description
    Consumption of two 12-ounce doses of pasteurized 100% watermelon juice for a four-week period
    Arm Title
    Consumption of a placebo beverage
    Arm Type
    Placebo Comparator
    Arm Description
    Consumption of a placebo beverage with comparable sugar content, pH, taste, texture, and color for a four-week period
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    100% watermelon juice
    Intervention Description
    Participants drank two 12-ounce servings of 100% watermelon juice per day for a four-week period.
    Intervention Type
    Other
    Intervention Name(s)
    Placebo beverage
    Intervention Description
    Participants drank two 12-ounce servings of a placebo beverage per day for a four-week period.
    Primary Outcome Measure Information:
    Title
    Change From Baseline in Serum Levels of Lycopene at 4 Weeks
    Description
    Lycopene determined by ultra high performance liquid chromatography with photodiode array detector (UPLC-PDA).
    Time Frame
    Baseline and 4 Weeks
    Title
    Change in Vascular Endothelial Function at 4 Weeks
    Description
    Determined by brachial artery flow-mediated dilation (FMD). FMD uses ultrasound technology to quantify changes in brachial artery diameter in response to hyperemia. A blood pressure cuff was placed distal to the brachial artery of the right arm with the participant supine and rested. Pre-inflation diameter was recorded for one minute, and the cuff was inflated to 50 mmHg above resting SBP for five minutes. Then, images were recorded for 120 seconds after cuff deflation. Peak diameter was determined as an average of the five highest measurements over five seconds post-deflation. FMD was expressed as the percentage increase in peak diameter.
    Time Frame
    Baseline and 4 weeks
    Title
    Change in Arterial Stiffness at 4 Weeks
    Description
    Determined by pulse wave velocity (PWV). A cuff-based system was used to measure brachial oscillometric pressure waveforms and generate central pressure curves by propriety algorithms. PWV was quantified as the rate at which a pulse wave moves down a vessel.
    Time Frame
    Baseline and 4 weeks

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    55 Years
    Maximum Age & Unit of Time
    69 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Ambulatory Female Age 55-69 years Body mass index 18.5 - 29.9 kg/m2 (non-obese) Exclusion Criteria: Food allergy to watermelon History of hypotension, chronic hypertension, chronic kidney disease, diabetes, previous cardiac events or procedures, phenylketonuria Smoking or other tobacco use Use of anticoagulant medications, cholesterol-lowering medications, blood-pressure medications, vasodilatory dietary supplements (garlic, fish oil), or dietary supplements containing lycopene, ascorbic acid, L-glutamine, L-arginine, or L-citrulline Weight change > 10% in the previous year
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Amy C Ellis, PhD, RD
    Organizational Affiliation
    University of Alabama at Birmingham
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Kristi Crowe-White, PhD, RD
    Organizational Affiliation
    University of Alabama at Birmingham
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    27897608
    Citation
    Ellis AC, Dudenbostel T, Locher JL, Crowe-White K. Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study. J Nutr Gerontol Geriatr. 2016 Oct-Dec;35(4):219-242. doi: 10.1080/21551197.2016.1250693.
    Results Reference
    background
    PubMed Identifier
    34344546
    Citation
    Ellis AC, Mehta T, Nagabooshanam VA, Dudenbostel T, Locher JL, Crowe-White KM. Daily 100% watermelon juice consumption and vascular function among postmenopausal women: A randomized controlled trial. Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2959-2968. doi: 10.1016/j.numecd.2021.06.022. Epub 2021 Jul 7.
    Results Reference
    derived
    PubMed Identifier
    32695957
    Citation
    Crowe-White KM, Voruganti VS, Talevi V, Dudenbostel T, Nagabooshanam VA, Locher JL, Ellis AC. Variation of Serum Lycopene in Response to 100% Watermelon Juice: An Exploratory Analysis of Genetic Variants in a Randomized Controlled Crossover Study. Curr Dev Nutr. 2020 Jun 17;4(7):nzaa102. doi: 10.1093/cdn/nzaa102. eCollection 2020 Jul.
    Results Reference
    derived

    Learn more about this trial

    Bioactive Compounds in Watermelon Modulating Oxidative Stress and Inflammation in Elders

    We'll reach out to this number within 24 hrs